Shengjian Li

发表

Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor.

S. Emanuel, R. Lin, P. Connolly, 2007, Bioorganic & medicinal chemistry letters.

Ultrathin-layered MoS2 hollow nanospheres decorating Ni3S2 nanowires as high effective self-supporting electrode for hydrogen evolution reaction

Y. Jiao, Ruihong Wang, Jun Wu, 2020 .

Copper Cyanide-Catalyzed Palladium Coupling of N-tert-Butoxycarbonyl-Protected α-Lithio Amines with Aryl Iodides or Vinyl Iodides.

R. Dieter, Shengjian Li, 1998 .

Copper Cyanide-Catalyzed Palladium Coupling of N-tert-Butoxycarbonyl-Protected α-Lithio Amines with Aryl Iodides or Vinyl Iodides

Shengjian Li, R. and, 1997 .

Synthesis, In Vitro Activities of (2-Cyclopropoxyphenyl)piperidine Derivatives for α1a and α1d Adrenergic Receptor Inhibitors

P. Connolly, S. Middleton, V. Pulito, 2009 .

(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).

P. Connolly, S. Middleton, V. Pulito, 2007, Bioorganic & medicinal chemistry letters.

Binary Metal Phosphides with MoP and FeP Embedded in P,N-Doped Graphitic Carbon As Electrocatalysts for Oxygen Reduction

Ruihong Wang, Z. Ren, Jun Wu, 2019, ACS Sustainable Chemistry & Engineering.

Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.

S. Emanuel, R. H. Gruninger, R. Lin, 2007, Bioorganic & medicinal chemistry letters.

Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity.

W. Greenlee, J. Lachowicz, J. Clader, 2004, Bioorganic & medicinal chemistry.

Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.

S. Emanuel, R. Lin, Angel R. Fuentes-Pesquera, 2007, Bioorganic & medicinal chemistry letters.

A Serendipitous Synthesis of Bis-Heterocyclic Spiro 3(2H)-Furanones.

R. Dieter, A. Picado, Shengjian Li, 2016, The Journal of organic chemistry.

Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists.

Ruo Xu, William J Greenlee, Daniel J Weston, 2006, Bioorganic & medicinal chemistry.

Copper cyanide catalyzed palladium coupling of α-lithio amines and aryl iodides

R. Dieter, Shengjian Li, R. Dieter, 1995 .

Nano α-FeOOH Modified Carbon Paste Electrode for Arsenic Determination in Natural Waters

Huiping Bai, Dongxian Zhang, Rui Zhang, 2018, Materials Science.

1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.

P. Connolly, S. Middleton, V. Pulito, 2007, Bioorganic & medicinal chemistry letters.

Coupling Reactions of α-(N-Carbamoyl)alkylcuprates with Enol Triflates Derived from Cyclic β-Keto Esters: A Facile Approach to γ-Carbamoyl-α,β-enoates

R. Dieter, Shengjian Li, 2003 .

α1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms

P. Connolly, S. Middleton, A. Reitz, 2008 .

(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).

P. Connolly, S. Middleton, V. Pulito, 2008, Bioorganic & medicinal chemistry letters.

Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).

P. Connolly, S. Middleton, Sean X Peng, 2007, Bioorganic & medicinal chemistry letters.

(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).

P. Connolly, S. Middleton, V. Pulito, 2007, Bioorganic & medicinal chemistry letters.

Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.

Ruo Xu, William J Greenlee, Anandan Palani, 2005, Journal of medicinal chemistry.